journal article·2019-07-12Open access

The Role of In Vitro Immune Response Assessment for Biomaterials

Alistair Lock, Jillian Cornish, David S. Musson

Abstract

Grafts are required to restore tissue integrity and function. However, current gold standard autografting techniques yield limited harvest, with high rates of complication. In the search for viable substitutes, the number of biomaterials being developed and studied has increased rapidly. To date, low clinical uptake has accompanied inherently high failure rates, with immune rejection a specific and common end result. The objective of this review article was to evaluate published immune assays evaluating biomaterials, and to stress the value that incorporating immune assessment into evaluations carries. Immunogenicity assays have had three areas of focus: cell viability, maturation and activation, with the latter being the focus in the majority of the literature due to its relevance to functional outcomes. With recent studies suggesting poor correlation between current in vitro and in vivo testing of biomaterials, in vitro immune response assays may be more relevant and enhance ability in predicting acceptance prior to in vivo application. Uptake of in vitro immune response assessment will allow for substantial reductions in experimental time and resources, including unnecessary and unethical animal use, with a simultaneous decrease in inappropriate biomaterials reaching clinic. This improvement in bench to bedside safety is paramount to reduce patient harm.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medicine, University of Auckland, Auckland 1142, New Zealand

Funding

Seventh Framework Programme

References (67)

Show source-provided references
1. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering10.1243/09544119JEIM770 ↗
2. Complication of anterior iliac bone graft harvesting in 372 adult patients from May 2006 to May 2011 and a literature review10.1055/s-0033-1357510 ↗
3. Recent advances in bone tissue engineering scaffolds10.1016/j.tibtech.2012.07.005 ↗
4. Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts10.1002/bit.24559 ↗
5. Bone regenerative medicine: Classic options, novel strategies, and future directions10.1186/1749-799X-9-18 ↗
6. (2018, August 01). Manufacturer and User Facility Device Experience Database—(MAUDE), Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm.
7. Restore Orthobiologic Implant: Not Recommended for Augmentation of Rotator Cuff Repairs
8. Acute Airway Obstruction in Cervical Spinal Procedures with Bone Morphogenetic Proteins10.1002/lary.21096 ↗
9. Complications Related to Osteobiologics Use in Spine Surgery: A Systematic Review10.1097/BRS.0b013e3181d81ef2 ↗
10. ISO Editor (2009). Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing within a Risk Management Process, ISO.
11. A surprisingly poor correlation between in vitro and in vivo testing of biomaterials for bone regeneration: Results of a multicentre analysis10.22203/eCM.v031a20 ↗
12. Biocompatibility of implants: Lymphocyte/macrophage interactions10.1007/s00281-011-0244-1 ↗
13. Mechanisms of biomaterial-induced superoxide release by neutrophils10.1002/jbm.820280313 ↗
14. A review on macrophage responses to biomaterials10.1088/1748-6041/1/1/R01 ↗
15. Immune responses to implants—A review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
16. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries10.1002/jbm.a.31863 ↗
17. Impact of 3-D printed PLA-and chitosan-based scaffolds on human monocyte/macrophage responses: Unraveling the effect of 3-D structures on inflammation10.1016/j.actbio.2013.10.035 ↗
18. Macrophage-mediated degradation of crosslinked collagen scaffolds10.1016/j.actbio.2010.08.005 ↗
19. Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates10.1016/j.biomaterials.2011.10.066 ↗
20. In vitro evaluations of innate and acquired immune responses to electrospun polydioxanone–elastin blends10.1016/j.biomaterials.2008.09.019 ↗
21. Modulation of murine innate and acquired immune responses following in vitro exposure to electrospun blends of collagen and polydioxanone10.1002/jbm.a.32579 ↗
22. The role of macrophage phenotype in vascularization of tissue engineering scaffolds10.1016/j.biomaterials.2014.02.012 ↗
23. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction10.1007/s10439-013-0933-0 ↗
24. in vitro response of macrophage polarization to a keratin biomaterial10.1016/j.actbio.2014.04.003 ↗
25. Fluorescence activated cell sorting10.1063/1.1685647 ↗
26. Differential functional effects of biomaterials on dendritic cell maturation10.1016/j.actbio.2012.06.006 ↗
27. In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration10.1089/ten.tea.2014.0128 ↗
28. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component10.1016/j.biomaterials.2008.11.040 ↗
29. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials10.1016/j.actbio.2011.11.031 ↗
30. Induction of immune gene expression and inflammatory mediator release by commonly used surgical suture materials: An experimental in vitro study10.1186/s13037-017-0132-2 ↗
31. Anisotropic cytocompatible electrospun scaffold for tendon tissue engineering elicits limited inflammatory response in vitro10.1177/0885328218779846 ↗
32. Enzyme-linked immunosorbent assay10.1080/01971520009349533 ↗
33. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers10.1002/jbm.820260702 ↗
34. TNF and IL-1 generation by human monocytes in response to biomaterials10.1002/jbm.820260703 ↗
35. A novel method to in vitro evaluate biocompatibility of nanoscaled scaffolds10.1002/jbm.a.35743 ↗
36. in vitro evaluation of the risk of inflammatory response after chitosan/HA and chitosan/β-1, 3-glucan/HA bone scaffold implantation10.1016/j.msec.2015.12.066 ↗
37. Chemokine and inflammatory cytokine changes during chronic wound healing10.1046/j.1524-475X.1997.50405.x ↗
38. Physiology and healing dynamics of chronic cutaneous wounds10.1016/S0002-9610(98)00183-4 ↗
39. Initial immune reaction and angiogenesis in bone healing10.1002/term.1505 ↗
40. Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds10.1016/j.biomaterials.2013.02.065 ↗
41. Protein microarray technology10.1016/S1359-6446(00)01910-2 ↗
42. Lymphocyte/macrophage interactions: Biomaterial surface-dependent cytokine, chemokine, and matrix protein production10.1002/jbm.a.31630 ↗
43. Cytometric bead array: A multiplexed assay platform with applications in various areas of biology10.1016/j.clim.2003.11.017 ↗
44. in vitro model to study the biomaterial-dependent reaction of macrophages in an inflammatory environment10.1002/bjs.9523 ↗
45. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro10.1006/cyto.2002.1048 ↗
46. Real time quantitative PCR10.1101/gr.6.10.986 ↗
47. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes10.1161/01.ATV.0000168412.50855.9f ↗
48. Jin, L., Wu, J., Yuan, G., and Chen, T. (2018). In vitro study of the inflammatory cells response to biodegradable Mg-based alloy extract. PLoS ONE, 13.10.1371/journal.pone.0193276 ↗
49. The effect of strontium incorporation into sol-gel biomaterials on their protein adsorption and cell interactions10.1016/j.colsurfb.2018.10.075 ↗
50. Osteoimmunomodulatory properties of magnesium scaffolds coated with β-tricalcium phosphate10.1016/j.biomaterials.2014.06.038 ↗
51. Novel in vitro comparative model of osteogenic andinflammatory cell response to dental implants10.1016/j.dental.2018.11.011 ↗
52. Macrophage phenotypes in the collagen-induced foreign body reaction in rats10.1016/j.actbio.2013.01.022 ↗
53. Evaluation of epigallocatechin-3-gallate (EGCG)-modified scaffold determines macrophage recruitment10.1016/j.msec.2019.03.007 ↗
54. Biomaterial-induced macrophage activation and monokine release10.3109/08941939409015357 ↗
55. Collagen-chitosan 3D nano-scaffolds effects on macrophage phagocytosis and pro-inflammatory cytokine release10.3109/1547691X.2016.1139642 ↗
56. Reactive oxygen species: Metabolism, oxidative stress, and signal transduction10.1146/annurev.arplant.55.031903.141701 ↗
57. In vitro studies of carbon nanotubes biocompatibility10.1016/j.carbon.2005.11.022 ↗
58. Current Methods Applied to Biomaterials –Characterization Approaches, Safety Assessment and Biological International Standards10.2174/1568026618666180410151518 ↗
59. Animal welfare and ISO—The International Organisation for Standardization
60. The need for thorough in vitro testing of biomaterial scaffolds: Two case studies10.1016/j.proeng.2013.05.103 ↗
61. Barriers to the clinical translation of orthopaedic tissue engineering10.1089/ten.teb.2011.0228 ↗
62. Scaffold translation: Barriers between concept and clinic10.1089/ten.teb.2011.0251 ↗
63. Predicting in vivo responses to biomaterials via combined in vitro and in silico analysis10.1089/ten.tec.2014.0167 ↗
64. In Vitro Chemotaxis and Tissue Remodeling Assays Quantitatively Characterize Foreign Body Reaction
65. A comparative multi-parametric in vitro model identifies the power of test conditions to predict the fibrotic tendency of a biomaterial10.1038/s41598-017-01584-9 ↗
66. Heparinization of Beta Tricalcium Phosphate: Osteo-immunomodulatory Effects10.1002/adhm.201700867 ↗
67. Becker, M., Quabius, S., Kewitz, T., Hansen, L., Becker, G., Kern, M., Kerston, H., and Harder, S. (2019). In vitro proinflammatory gene expression changes in human whole blood after contact with plasma-treated implant surfaces. J. Cranio-Maxillofac. Surg.10.1016/j.jcms.2019.05.004 ↗